Q3UDE2
Gene name |
Ttll12 |
Protein name |
Tubulin--tyrosine ligase-like protein 12 |
Names |
Inactive tubulin--tyrosine ligase-like protein 12 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:223723 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3UDE2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3UDE2-F1 | Predicted | AlphaFoldDB |
36 variants for Q3UDE2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3389385625 | 49 | H>D | No | EVA | |
| rs3389342096 | 52 | E>K | No | EVA | |
| rs3389381913 | 79 | R>W | No | EVA | |
| rs31717119 | 83 | R>K | No | EVA | |
| rs3389347035 | 87 | N>T | No | EVA | |
| rs3389347053 | 100 | S>N | No | EVA | |
| rs3389376261 | 101 | E>K | No | EVA | |
| rs3413119009 | 104 | V>I | No | EVA | |
| rs3389369103 | 106 | A>T | No | EVA | |
| rs3389380779 | 121 | C>* | No | EVA | |
| rs3389393764 | 142 | N>Y | No | EVA | |
| rs3389371863 | 165 | M>I | No | EVA | |
| rs3389297603 | 185 | V>A | No | EVA | |
| rs3406067579 | 222 | W>G | No | EVA | |
| rs3389379636 | 258 | D>N | No | EVA | |
| rs3389372996 | 289 | I>V | No | EVA | |
| rs3389385630 | 299 | V>I | No | EVA | |
| rs3405820836 | 321 | T>S | No | EVA | |
| rs3405478128 | 325 | A>G | No | EVA | |
| rs3389380862 | 339 | Y>* | No | EVA | |
| rs3389340537 | 340 | M>K | No | EVA | |
| rs3389297623 | 348 | Q>* | No | EVA | |
| rs3389372960 | 352 | N>S | No | EVA | |
| rs3389393805 | 422 | L>M | No | EVA | |
| rs3389379655 | 438 | E>K | No | EVA | |
| rs3389371831 | 439 | S>N | No | EVA | |
| rs3389358296 | 446 | K>N | No | EVA | |
| rs3389347033 | 461 | N>K | No | EVA | |
| rs3389369104 | 474 | S>P | No | EVA | |
| rs3389340582 | 508 | T>I | No | EVA | |
| rs3406464522 | 512 | Y>S | No | EVA | |
| rs3389380786 | 552 | E>V | No | EVA | |
| rs3389393737 | 579 | D>N | No | EVA | |
| rs3389372961 | 579 | D>V | No | EVA | |
| rs3389380801 | 599 | L>V | No | EVA | |
| rs3389375259 | 619 | N>S | No | EVA |
No associated diseases with Q3UDE2
No regional properties for Q3UDE2
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q3UDE2 | |||
Functions
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| microtubule organizing center | An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides. |
| midbody | A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| spindle | The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| acid-amino acid ligase activity | Catalysis of the ligation of an acid to an amino acid via a carbon-nitrogen bond, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. |
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| H4K20me3 modified histone binding | Binding to a histone H4 in which the lysine residue at position 20 has been modified by trimethylation. |
| tubulin binding | Binding to monomeric or multimeric forms of tubulin, including microtubules. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| negative regulation of type I interferon-mediated signaling pathway | Any process that decreases the rate, frequency or extent of a type I interferon-mediated signaling pathway. |
| protein modification process | The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification). |
| regulation of mitotic cell cycle | Any process that modulates the rate or extent of progress through the mitotic cell cycle. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEIQSGPQPG | SPGRAERLNA | RLLDEFVSLH | GPTLRASGVP | ERLWGRLLHK | LEHEVFDAGE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| MFGIMQVEEV | EEAEDEAARE | AQRKQPNPGG | ELCYKVIVTS | ESGVRADDPN | SIFLIDHAWT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| CRVEHARKQL | QQVPGLLHRM | ANLMGIEFHG | EVPSPEVVAL | VLEEMWKFNQ | TYQLAHGTAE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EKVPVWYIMD | EFGSRIQHSD | MPSFATAPFF | YMPQQVAYTL | LWPLRDLDTG | EEVTRDFAYG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| EADPLIRKCM | LLPWAPADML | DLSFSTPEPP | AKYYQAILEE | NKEKLPLAIS | PVARPQGHVF |
| 310 | 320 | 330 | 340 | 350 | 360 |
| RVHCDVQQVL | GHLTHPRFTF | TDSEADADIF | FHFSHFKDYM | KLSQESPQVL | LNQFPCENLL |
| 370 | 380 | 390 | 400 | 410 | 420 |
| TVKDCLASIA | RRAGGPEGPP | WLPRTFNLRT | ELPQFVSYFQ | HRERRGEDNH | WICKPWNLAR |
| 430 | 440 | 450 | 460 | 470 | 480 |
| SLDTHVTNNL | HSIIRHREST | PKVVSKYIES | PVLFLREDVG | NVKFDIRYIV | LLRSVRPLRL |
| 490 | 500 | 510 | 520 | 530 | 540 |
| FAYDVFWLRF | SNRPFALDDL | DDYEKHFTVM | NYDPDVVLKQ | VHYNEFIPQF | EKQYPEFPWS |
| 550 | 560 | 570 | 580 | 590 | 600 |
| DVQAEIFKAF | TELFQVACAK | PPPMGLCDYP | SSRAMYAIDL | MLNWDNHPDG | KRVMQPQILE |
| 610 | 620 | 630 | |||
| VNFNPDCERA | CRYHPSFFND | VFSTLFLDET | DNCHVTRII |